Mysore Kalappa Sudarshan
Overview
Explore the profile of Mysore Kalappa Sudarshan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
93
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Thangaraj J, Krishna N, Devika S, Egambaram S, Dhanapal S, Khan S, et al.
Lancet Infect Dis
. 2024 Oct;
25(1):126-134.
PMID: 39362224
Background: Reliable and recent data of human rabies deaths and animal bites are not available in India, where a third of global cases occur. Since there is a global target...
2.
Rajagopal Padma M, Dinesh P, Sundaresan R, Athreya S, Shiju S, Maroor P, et al.
IJID Reg
. 2024 Feb;
10:150.
PMID: 38314395
[This corrects the article DOI: 10.1016/j.ijregi.2021.10.008.].
3.
Rajagopal Padma M, Dinesh P, Sundaresan R, Athreya S, Shiju S, Maroor P, et al.
IJID Reg
. 2022 Jun;
1:107-116.
PMID: 35721769
Objective: Demonstrate the feasibility of using the existing sentinel surveillance infrastructure to conduct the second round of the serial cross-sectional sentinel-based population survey. Assess active infection, seroprevalence, and their evolution...
4.
Babu G, Sundaresan R, Athreya S, Akhtar J, Pandey P, Maroor P, et al.
Int J Infect Dis
. 2021 May;
108:27-36.
PMID: 34029705
Objective: To estimate the burden of active infection and anti-SARS-CoV-2 IgG antibodies in Karnataka, India, and to assess variation across geographical regions and risk groups. Methods: A cross-sectional survey of...
5.
Sudarshan M, Ashwath Narayana D
Indian J Public Health
. 2019 Oct;
63(Supplement):S51-S53.
PMID: 31603093
National Rabies Control Programme, India, is in operation since 2012-2013 without much impact due to poor funding and no set policy for the rabies prevention and control. An effort was...
6.
Sudarshan M, Ashwath Narayana D, Jayakrishnappa M
Indian J Public Health
. 2019 Oct;
63(Supplement):S37-S43.
PMID: 31603090
Background: Rabies vaccines and immunoglobulins are lifesaving in humans following animal exposures. These biologicals should continuously be available throughout the year to prevent and eliminate human rabies by 2030. Objectives:...
7.
Sudarshan M, Haradanhalli R
Indian J Public Health
. 2019 Oct;
63(Supplement):S26-S30.
PMID: 31603088
Background: The rabies postexposure prophylaxis (PEP) is provided through anti-rabies clinics in the country. It was considered important to assess their facilities under a nationwide multi-centric survey. Objectives: The objective...
8.
Sudarshan M, Ashwath Narayana D
Indian J Public Health
. 2019 Oct;
63(Supplement):S3-S8.
PMID: 31603084
Background: The key to understanding the burden of animal bites and rabies lies in accurate and timely data with the help of proper surveillance system across the country. Such a...
9.
Sudarshan M, Ashwath Narayana D
Indian J Public Health
. 2019 Oct;
63(Suppl 1):S1.
PMID: 31603082
No abstract available.
10.
Ashwath Narayana D, Madhusudana S, Sampath G, Tripathy R, Sudarshan M, Gangaboraiah , et al.
Hum Vaccin Immunother
. 2013 Sep;
10(1):120-5.
PMID: 24030586
Zydus Cadila Health care, India developed a new purified chick embryo cell rabies vaccine (PCECV, Vaxirab-N; 1 mL) by adapting Pitman-Moore strain of virus on to the chick embryo fibroblast...